Jefferies Upgrades Minerva Neurosciences (NERV) to Buy

August 14, 2026 4:04 AM

Jefferies analyst Andrew Tsai upgraded Minerva Neurosciences (NASDAQ: NERV) from Hold to Buy with a price target of $10.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found